SCHEMBL23913798

SCHEMBL23913798

c1ccc(-c2ccc3c(c2)oc2cc(-c4nc(-c5ccc(-c6cccc7oc8ccccc8c67)cc5)nc(-c5ccc6c(c5)oc5ccccc56)n4)ccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.41
MMP12 P39900 1/20 0.40
MMP13 P45452 1/20 0.40
AHR P35869 1/20 0.39
PLA2G2A P14555 3/20 0.38
PLA2G4A P47712 3/20 0.38
BACE1 P56817 1/20 0.38
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 4/20 0.38
MAPT P10636 3/20 0.38
HPGD P15428 3/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ALOX5 P09917 1/20 0.37
HSD17B10 Q99714 2/20 0.37
ATM Q13315 2/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
NFKB1 P19838 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21148561 1.00 HCRTR1 (0.41) HCRTR1MMP12MMP13AHRPLA2G2A
SCHEMBL25645750 1.00 HCRTR1 (0.41) HCRTR1MMP12MMP13AHRPLA2G2A
SCHEMBL25851894 1.00 HCRTR1 (0.41) HCRTR1MMP12MMP13AHRPLA2G2A
SCHEMBL23913842 1.00 HCRTR1 (0.41) HCRTR1MMP12MMP13AHRPLA2G2A
SCHEMBL25645661 0.99 HCRTR1 (0.41) HCRTR1MMP12MMP13AHRPLA2G2A
SCHEMBL21149259 0.99 HCRTR1 (0.41) HCRTR1MMP12MMP13AHRPLA2G2A
SCHEMBL25851895 0.99 HCRTR1 (0.41) HCRTR1MMP12MMP13AHRPLA2G2A
SCHEMBL21108831 0.99 HCRTR1 (0.40) HCRTR1MMP12MMP13AHRPLA2G2A
SCHEMBL22763866 0.99 HCRTR1 (0.40) HCRTR1MMP12MMP13AHRPLA2G2A
SCHEMBL21148512 0.99 HCRTR1 (0.40) HCRTR1MMP12MMP13AHRPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, TRPC1 HCRTR1 476/4885MMP12 4705/4885MMP13 4830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.